ata188: an allogeneic ebv-specific t cell therapy for progressive ms
Published 3 years ago • 534 plays • Length 5:20Download video MP4
Download video MP3
Similar videos
-
2:58
ata188 in ebv progressive multiple sclerosis
-
4:08
characterization of ata188: an off-the-shelf therapy for ms
-
13:38
ata 188 for multiple sclerosis (anti-ebv neurogenic t-cell therapy from atara biotherapeutics)
-
5:18
adoptive transfer of ebv-specific t cells in patients with multiple sclerosis
-
3:59
ata3219, ata3271 & ata188: t-cell immunotherapy products in development
-
3:48
jakob dupont, md: epstein-barr virus targeted agent ata188 in progressive ms
-
4:55
advances in cell-based therapies for ms
-
8:39
jakob dupont, md: phase 1 data on cell therapy for progressive ms
-
3:12
anti-ebv trial shows promise in progressive ms
-
5:02
am2020-willmer-id27
-
40:47
episode 219: update on an investigational stem cell therapy for ms with dr. aj joshi
-
11:17
multiple sclerosis & ata188
-
2:59
tabelecleucel in ebv-associated ptld
-
2:21
tab-cel for solid organ or allogeneic transplant recipients with ebv-ptld
-
3:29
tabelecleucel for treating ebv associated ptld
-
1:16
αβ t-cell depleted allo-hsct for hematological malignancies
-
2:03
the role of epstein-barr virus in the pathogenesis of ms
-
3:34
neurology news network: week of october 16